Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RPRX | RVMD | BIIB | ||
| Company | Royalty Pharma Plc Cl A | Revolution Medicines Inc | Biogen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 49.55 | 151.85 | 179.54 | ||
| High | 50.08 | 153.50 | 184.26 | ||
| Low | 49.25 | 146.17 | 178.72 | ||
| Latest | 49.30 | 146.23 | 183.34 | ||
| Change | -0.70 | -2.40 | +5.99 | ||
| % Change | -1.40% | -1.61% | +3.38% | ||
| Volume | 2,524,200 | 3,494,100 | 1,480,300 | ||
| 20-Day Average Volume | 2,833,670 | 3,638,230 | 1,301,240 | ||
| Previous Close | 50.00 | 148.63 | 177.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 47.75 | 111.05 | 180.71 | ||
| 20-Day Raw Stochastic | 84.61% | 85.24% | 62.20% | ||
| 20-Day Relative Strength | 62.52 | 76.25 | 51.26 | ||
| Weighted Alpha | +56.46 | +138.29 | +48.94 | ||
| Today's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 8% Buy | ||
| Last Month's Opinion | 88% Buy | 40% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.80% since 04/13/26 | +7.29% since 04/13/26 | +3.95% since 04/13/26 | ||
| Low | 48.08 on 04/15/26 | 134.66 on 04/14/26 | 174.85 on 04/16/26 | ||
| High | 50.08 on 04/20/26 | 155.70 on 04/16/26 | 184.26 on 04/20/26 | ||
| 1-Month | |||||
| %Chg | +8.69% since 03/20/26 | +52.67% since 03/20/26 | +1.04% since 03/20/26 | ||
| Low | 45.04 on 03/23/26 | 91.52 on 03/30/26 | 168.64 on 04/06/26 | ||
| High | 50.08 on 04/20/26 | 155.70 on 04/16/26 | 192.27 on 03/26/26 | ||
| 3-Month | |||||
| %Chg | +26.12% since 01/20/26 | +25.82% since 01/20/26 | +10.86% since 01/20/26 | ||
| Low | 39.02 on 01/21/26 | 91.52 on 03/30/26 | 165.31 on 01/21/26 | ||
| High | 50.08 on 04/20/26 | 155.70 on 04/16/26 | 202.41 on 02/06/26 | ||
| 6-Month | |||||
| %Chg | +34.59% since 10/20/25 | +170.75% since 10/20/25 | +25.04% since 10/20/25 | ||
| Low | 35.92 on 10/28/25 | 52.48 on 10/23/25 | 138.00 on 10/30/25 | ||
| High | 50.08 on 04/20/26 | 155.70 on 04/16/26 | 202.41 on 02/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 28,842,850 | 29,454,456 | 26,027,710 | ||
| Shares Outstanding, K | 576,857 | 198,173 | 146,759 | ||
| Annual Sales | 2,378,190,000 | 0 | 9,890,600,000 | ||
| Annual Net Income | 770,950,000 | -1,131,300,000 | 1,292,900,000 | ||
| Last Quarter Sales | 621,990,000 | 0 | 2,279,400,000 | ||
| Last Quarter Net Income | 214,210,000 | -364,890,000 | -48,900,000 | ||
| 60-Month Beta | 0.39 | 1.01 | 0.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.46 on 02/11/26 | -1.86 on 02/25/26 | 1.99 on 02/06/26 | ||
| Latest Earnings Date | 05/06/26 | 05/06/26 | 04/29/26 | ||
| Most Recent Dividend | 0.235 on 02/20/26 | N/A | N/A | ||
| Next Ex-Dividends Date | 05/15/26 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.04 | 0.00 | 11.51 | ||